(0.00%) 5 187.67 points
(0.44%) 39 056 points
(-0.18%) 16 303 points
(0.33%) $79.25
(-0.46%) $2.18
(-0.26%) $2 316.20
(-0.11%) $27.57
(0.03%) $984.90
(0.05%) $0.931
(0.15%) $10.91
(0.03%) $0.800
(0.01%) $91.75
Live Chart Being Loaded With Signals
Viva Biotech Holdings, an investment holding company, provides structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide...
Stats | |
---|---|
आज की मात्रा | 4.62M |
औसत मात्रा | 5.09M |
बाजार मूल्य | 1.24B |
EPS | HKD0 ( 2023-08-29 ) |
अगली कमाई की तारीख | ( HKD0 ) 2024-06-26 |
Last Dividend | HKD0.0100 ( 2021-06-16 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | -3.87 |
ATR14 | HKD0.00200 (0.34%) |
मात्रा सहसंबंध
VIVA Biotech Holdings सहसंबंध
10 सबसे अधिक सकारात्मक सहसंबंध |
---|
10 सबसे अधिक नकारात्मक सहसंबंध |
---|
क्या आप जानते हैं?
कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।
कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।
VIVA Biotech Holdings सहसंबंध - मुद्रा/वस्त्र
VIVA Biotech Holdings वित्तीय
Annual | 2023 |
राजस्व: | HKD2.16B |
सकल लाभ: | HKD738.43M (34.26 %) |
EPS: | HKD-0.0598 |
FY | 2023 |
राजस्व: | HKD2.16B |
सकल लाभ: | HKD738.43M (34.26 %) |
EPS: | HKD-0.0598 |
FY | 2022 |
राजस्व: | HKD2.38B |
सकल लाभ: | HKD815.68M (34.28 %) |
EPS: | HKD-0.280 |
FY | 2021 |
राजस्व: | HKD2.10B |
सकल लाभ: | HKD650.98M (30.94 %) |
EPS: | HKD0.150 |
Financial Reports:
No articles found.
VIVA Biotech Holdings Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
First Dividend | HKD0.00500 | 2019-09-09 |
Last Dividend | HKD0.0100 | 2021-06-16 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 4 | -- |
Total Paid Out | HKD0.0470 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.9 | -- |
Div. Sustainability Score | 7.09 | |
Div.Growth Potential Score | 1.999 | |
Div. Directional Score | 4.54 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
3669.HK | Ex Dividend Junior | 2023-09-07 | Annually | 0 | 0.00% | |
1618.HK | Ex Dividend Junior | 2023-07-27 | Annually | 0 | 0.00% | |
0669.HK | Ex Dividend Knight | 2023-08-29 | Semi-Annually | 0 | 0.00% | |
9997.HK | Ex Dividend Knight | 2023-05-30 | Annually | 0 | 0.00% | |
2199.HK | Ex Dividend Junior | 2023-09-18 | Annually | 0 | 0.00% | |
1203.HK | Ex Dividend Knight | 2023-10-03 | Semi-Annually | 0 | 0.00% | |
0267.HK | Ex Dividend Junior | 2023-09-22 | Semi-Annually | 0 | 0.00% | |
3968.HK | Ex Dividend Knight | 2023-07-05 | Annually | 0 | 0.00% | |
1776.HK | Ex Dividend Junior | 2023-07-11 | Annually | 0 | 0.00% | |
0817.HK | Ex Dividend Junior | 2023-09-18 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.0539 | 1.500 | -1.077 | -1.616 | [0 - 0.5] |
returnOnAssetsTTM | -0.0156 | 1.200 | -0.520 | -0.623 | [0 - 0.3] |
returnOnEquityTTM | -0.0317 | 1.500 | -1.463 | -2.19 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.324 | 0.800 | 8.38 | 6.70 | [1 - 3] |
quickRatioTTM | 0.941 | 0.800 | 9.17 | 7.34 | [0.8 - 2.5] |
cashRatioTTM | 0.675 | 1.500 | 7.36 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.255 | -1.500 | 5.74 | -8.61 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.447 | 2.00 | 9.85 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.228 | 2.00 | 9.89 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.516 | -1.500 | 7.94 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.343 | 1.000 | 7.62 | 7.62 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0894 | 1.000 | -0.212 | -0.212 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.201 | 1.000 | 9.99 | 9.99 | [0.2 - 2] |
assetTurnoverTTM | 0.289 | 0.800 | -1.404 | -1.124 | [0.5 - 2] |
Total Score | 7.09 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -4.02 | 1.000 | -0.508 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0317 | 2.50 | -0.941 | -2.19 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.228 | 2.00 | 9.92 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.447 | 2.00 | 9.85 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.0206 | 1.500 | -3.47 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.178 | 1.000 | 8.05 | 0 | [0.1 - 0.5] |
Total Score | 1.999 |
VIVA Biotech Holdings
Viva Biotech Holdings, an investment holding company, provides structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide. The company provides discovery biology services, include protein expression and purification, structural biology, hit discovery, bioassay, biomolecular interaction, and pharmacokinetics; chemistry services, such as medicinal and synthetic chemistry, analytical chemistry, purification preparation, and computer-aided drug design services, as well as offers chemical technology platforms; and antibody drug research and development services, include antigen preparation, multi-species discovery, monoclonal antibodies, antibodies functional screening and identification, antibody engineering transformation, antibody characteristics, and antibody cell line engineering transformation, as well as offers technology platforms, such as hybridoma, phage and yeast display, mammalian display, VHH antibody technology, high throughput sequencing, computer-aided drug design, HDX-MS, crystal structure determination of protein, and SPR technology. It also provides cell lines, crystal structures, GPCR proteins, antibodies, and proteins. In addition, the company offers contract development and manufacturing services for small molecule active pharmaceutical ingredients (APIs) and intermediates; and trades in APIs, intermediates, and formulations, as well as equity for service. Further, it provides research service; laboratory rental services; and project management and bidding services, as well as sells compounds. The company was incorporated in 2008 and is headquartered in Shanghai, China.
के बारे में लाइव सिग्नल्स
इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।
लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं